The effect of semaglutide once weekly on MACE and blood pressure by race and ethnicity: SUSTAIN 6 post hoc analysis

被引：0
|
作者：
Desouza, C. [1 ]
Bain, S. C. [2 ]
Gondolf, T. [3 ]
Hansen, T. [3 ]
Holst, I. [3 ]
Rea, R. R. [4 ]
Seufert, J. [5 ]
机构：
[1] Univ Nebraska Med Ctr, Omaha, NE USA
[2] Swansea Univ, Sch Med, Swansea, W Glam, Wales
[3] Novo Nordisk AS, Soborg, Denmark
[4] Univ Fed Parana, Hosp Clin, Curitiba, Parana, Brazil
[5] Univ Freiburg, Med Ctr, Fac Med, Freiburg, Germany
来源：
EUROPEAN HEART JOURNAL | 2019年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P6271
引用
收藏
页码：3876 / 3876
页数：1
相关论文
共 50 条
  • [1] The effect of once-weekly semaglutide on MACE, blood pressure and lipids by race and ethnicity: a SUSTAIN 6 post hoc analysis
    Bain, S. C.
    Desouza, C. V.
    Gondolf, T.
    Hansen, T.
    Holst, I.
    Rea, R. R.
    Seufert, J.
    [J]. DIABETOLOGIA, 2019, 62 : S365 - S365
  • [2] Effect of once-weekly semaglutide on insulin use in subjects with type 2 diabetes: a post hoc analysis of SUSTAIN 6
    Seufert, J.
    Desouza, C.
    Kirk, A. R.
    Lawson, J.
    Lingvay, I.
    Sondergaard, A. L.
    Bain, S. C.
    [J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 251 - 252
  • [3] Efficacy and Safety of Semaglutide for Type 2 Diabetes by Race and Ethnicity: A Post Hoc Analysis of the SUSTAIN Trials
    DeSouza, Cyrus
    Cariou, Bertrand
    Garg, Satish
    Lausvig, Nanna
    Navarria, Andrea
    Fonseca, Vivian
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (02): : 543 - 556
  • [4] Efficacy and safety of semaglutide in subjects with type 2 diabetes by race and ethnicity: a post hoc analysis of the SUSTAIN trials
    Desouza, C.
    Garg, S.
    Cariou, B.
    Furberg, J. K.
    Navarria, A.
    Nayak, G.
    Fonseca, V.
    [J]. DIABETOLOGIA, 2018, 61 : S369 - S370
  • [5] Reduced glycaemic variability with once-weekly semaglutide vs active comparators in post hoc analysis of the SUSTAIN programme
    Jodar, E.
    Aroda, V. R.
    Kose, Y.
    Kaltoft, M.
    Sondergaard, A. L.
    Pratley, R.
    [J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 250 - 250
  • [6] Reduced Glycemic Variability with Once-Weekly Semaglutide vs. Active Comparators in Post-hoc Analysis of the SUSTAIN Program
    Pratley, Richard E.
    Aroda, Vanita R.
    Hindsberger, Charlotte
    Kose, Yasemin
    Kaltoft, Margit
    Jodar, Esteban
    [J]. DIABETES, 2021, 70
  • [7] Effect of semaglutide on MACE by baseline kidney function in participants with type 2 diabetes and high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc analysis
    Rossing, P.
    Bain, S.
    Bosch-Traberg, H.
    Frenkel, O.
    Heerspink, H. L.
    Rasmussen, S.
    Mellbin, L.
    [J]. DIABETOLOGIA, 2022, 65 (SUPPL 1) : S24 - S25
  • [8] Effects of once-weekly semaglutide on major adverse cardiovascular events in patients with type 2 diabetes and polyvascular disease: a post hoc analysis of the SUSTAIN 6 trial
    Kobo, O.
    Cavender, M. A.
    Gylvin, S. Hinsch
    Kuhlman, A. B.
    Rasmussen, S.
    Verma, S.
    [J]. EUROPEAN HEART JOURNAL, 2023, 44
  • [9] Impact of patient characteristics on efficacy and safety of once-weekly semaglutide versus dulaglutide: SUSTAIN 7 post hoc analyses
    Pratley, Richard E.
    Aroda, Vanita R.
    Catarig, Andrei-Mircea
    Lingvay, Ildiko
    Luedemann, Joerg
    Yildirim, Emre
    Viljoen, Adie
    [J]. BMJ OPEN, 2020, 10 (11):
  • [10] Impact of baseline characteristics on the efficacy of once-weekly subcutaneous semaglutide among participants with type 2 diabetes: A post hoc analysis of SUSTAIN China
    Ji, Linong
    Lu, Yibing
    Shen, Zewei
    Hu, Ping
    Liu, Wenyan
    Zhang, Qiu
    Shi, Bimin
    [J]. DIABETES OBESITY & METABOLISM, 2024,
12345